Sanuwave Health rises after $5M payment related to patent sale

Sanuwave's stock price rose following a $5 million cash inflow from a third-party licensee related to an acquisition option exercise.

The agreement, established on March 6, 2024, grants the licensee exclusive rights to various patents focused on intravascular shockwave applications.

Initially, the licensee paid Sanuwave a one-time licensing fee of $2.5 million for these exclusive rights and the option to purchase the patents outright.

As a result of this announcement, Sanuwave's shares surged by 8% on the day of the news.

Recommendation Rating: Positive Outlook on Sanuwave Shares

Sanuwave (NASDAQ:SNWV) experienced an increase in its stock price following the announcement of a $5 million cash inflow from a third-party licensee. This payment is associated with the exercise of an acquisition option that was granted earlier. The agreement, which was established on March 6, 2024, provided the licensee with exclusive rights to a range of patents related to intravascular shockwave applications. In return for these exclusive rights and the option to purchase the patents in full, the licensee initially paid Sanuwave a one-time licensing fee of $2.5 million. As a direct result of this news, shares of Sanuwave have surged by 8% today.